Mirae Asset Group
未来资产集团
Mirae Asset Group is a fund that has appeared as a co-investor in Chinese venture deals covered by elsewhere's corpus, notably participating in Xinhuazhang's Series B round in November 2022 alongside CICC Capital and Henglu Asset , and in Saint Bella's C-3 strategic financing in 2023 alongside C Capital, Swire Properties, and Shenqi Capital . The name appears in Chinese sources as "未来资产" (Future Asset). elsewhere's corpus does not cover this entity's broader profile, headquarters, or assets under management.
AI-generated — may contain errors, please verify.
Coverage
Healthcare and chip companies close new funding rounds; satellite communications, energy storage batteries, and other sectors hit milestones | Rongbao · July
Foresight and courage.
Saint Bella Closes Hundreds of Millions of Yuan in Series C Strategic Financing, Building a Global Leading Family Care Brand
Targeting the broader consumer-service scenarios of China's new-generation families.
Consumer/Medical Companies Launch New Products, Advanced Tech Market Share and Capacity Advance Further | Rongbao · November
Explore industry demand, and build solid R&D capabilities.
Xinhuazhang Closes Hundreds of Millions of RMB in Series B Funding, Doubles Down on Agile Verification to Power System-Level Innovation
Accelerating time-to-market from chip to system.
2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
December, Everything Within Reach | 5Y News Monthly
The big news from last month.
5Y News | Abogen Biosciences Completes $300 Million Series C+ Round
Contribute to the innovation-driven development of the biopharmaceutical industry.
The Best Is Always Ahead | 5Y News Monthly
Happy Labor Day!
5Y News | CloudWalk Group Closes $600 Million Series C2 Round to Expand Global Digital Supply Chain Services
A world-class supply chain that belongs to Chinese retail.
Morningside-backed XtalPi raises over $300 million in new funding | Light Moments
5Y Capital has long been bullish on the application of computational science in the life sciences, hoping that the convergence of IT and biotechnology will soon usher human health into a new era.
